MXCT
MaxCyte Inc
NASDAQ: MXCT · HEALTHCARE · MEDICAL DEVICES
$0.84
-3.24% today
Updated 2026-05-08
Market cap
$90.34M
P/E ratio
—
P/S ratio
2.74x
EPS (TTM)
$-0.42
Dividend yield
—
52W range
$1 – $2
Volume
0.9M
MaxCyte Inc (MXCT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.06M | $6.80M | $7.16M | $9.29M | $12.27M | $13.98M | $16.67M | $21.62M | $26.17M | $33.89M | $44.26M | $41.29M | $38.63M | $33.03M |
| Revenue growth (YoY) | — | +34.5% | +5.3% | +29.7% | +32.1% | +14.0% | +19.2% | +29.7% | +21.0% | +29.5% | +30.6% | -6.7% | -6.4% | -14.5% |
| Cost of revenue | $830400.00 | $808600.00 | $957500.00 | $1.03M | $1.31M | $1.45M | $1.84M | $2.50M | $2.77M | $3.65M | $5.10M | $4.74M | $7.10M | $10.45M |
| Gross profit | $4.23M | $6.00M | $6.21M | $8.26M | $10.96M | $12.53M | $14.83M | $19.12M | $23.40M | $30.25M | $39.16M | $36.55M | $31.53M | $22.58M |
| Gross margin | 83.6% | 88.1% | 86.6% | 88.9% | 89.3% | 89.6% | 89.0% | 88.4% | 89.4% | 89.2% | 88.5% | 88.5% | 81.6% | 68.4% |
| R&D | $2.21M | $2.22M | $2.49M | $3.01M | $4.70M | $11.28M | $11.24M | $17.59M | $17.73M | $15.41M | $19.51M | $23.82M | $22.23M | $20.82M |
| SG&A | $2.02M | $2.21M | $2.47M | $2.67M | $4.20M | $4.52M | $5.28M | $5.56M | $7.37M | $18.68M | $25.83M | $30.07M | $29.69M | $28.12M |
| Operating income | $-1.96M | $-804700.00 | $-1.28M | $-761100.00 | $-2.72M | $-9.29M | $-8.42M | $-12.42M | $-11.06M | $-18.19M | $-27.36M | $-48.30M | $-51.20M | $-43.55M |
| Operating margin | -38.8% | -11.8% | -17.8% | -8.2% | -22.2% | -66.4% | -50.5% | -57.4% | -42.3% | -53.7% | -61.8% | -117.0% | -132.5% | -131.9% |
| EBITDA | $-1.81M | $-688300.00 | $-1.18M | $-647800.00 | $-2.60M | $-9.15M | $-7.91M | $-11.60M | $-9.94M | $-16.61M | $-24.66M | $-44.13M | $-46.41M | $-38.40M |
| EBITDA margin | -35.8% | -10.1% | -16.5% | -7.0% | -21.2% | -65.4% | -47.5% | -53.7% | -38.0% | -49.0% | -55.7% | -106.9% | -120.1% | -116.3% |
| EBIT | $-1.93M | $-804700.00 | $-1.28M | $-741100.00 | $-2.71M | $-9.29M | $-8.25M | $-12.21M | $-10.99M | $-18.04M | $-27.36M | $-48.30M | $-51.20M | $-43.55M |
| Interest expense | $61700.00 | $153500.00 | $561300.00 | $704400.00 | $637800.00 | $625300.00 | $614600.00 | $681100.00 | $825600.00 | $1.04M | $126900.00 | — | — | — |
| Income tax | $35800.00 | — | — | $724400.00 | $653500.00 | — | $170300.00 | $681100.00 | $825600.00 | $1.04M | $-3.79M | $4.00M | — | — |
| Effective tax rate | -1.8% | 0.0% | 0.0% | -100.5% | -24.3% | 0.0% | -2.0% | -5.6% | -7.5% | -5.8% | 13.9% | -11.8% | 0.0% | 0.0% |
| Net income | $-1.99M | $-958200.00 | $-1.84M | $-1.45M | $-3.35M | $-9.92M | $-8.87M | $-12.89M | $-11.82M | $-19.08M | $-23.57M | $-37.92M | $-41.05M | $-44.63M |
| Net income growth (YoY) | — | +51.8% | -91.7% | +21.3% | -131.4% | -196.4% | +10.6% | -45.4% | +8.4% | -61.5% | -23.5% | -60.9% | -8.3% | -8.7% |
| Profit margin | -39.3% | -14.1% | -25.6% | -15.6% | -27.3% | -70.9% | -53.2% | -59.6% | -45.2% | -56.3% | -53.3% | -91.8% | -106.3% | -135.1% |